Last Updated: June 22, 2026

GALLIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Gallium patents expire, and when can generic versions of Gallium launch?

Gallium is a drug marketed by Curium, Ge Healthcare, Lantheus Medcl, Methodist, Uihc Pet Imaging, Univ Ca Los Angeles, and Univ Of Ca San Fran. and is included in seven NDAs.

The generic ingredient in GALLIUM is gallium ga-68 gozetotide. There are sixteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the gallium ga-68 gozetotide profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for GALLIUM?
  • What are the global sales for GALLIUM?
  • What is Average Wholesale Price for GALLIUM?
Summary for GALLIUM
US Patents:0
Applicants:7
NDAs:7
Drug Prices: Drug price information for GALLIUM
What excipients (inactive ingredients) are in GALLIUM?GALLIUM excipients list
DailyMed Link:GALLIUM at DailyMed

US Patents and Regulatory Information for GALLIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 018058-001 Approved Prior to Jan 1, 1982 BS RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Univ Ca Los Angeles GALLIUM GA 68 GOZETOTIDE gallium ga-68 gozetotide SOLUTION;INTRAVENOUS 212642-001 Dec 1, 2020 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Methodist GALLIUM GA 68 EDOTREOTIDE gallium ga-68 edotreotide SOLUTION;INTRAVENOUS 218845-001 Oct 10, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Univ Of Ca San Fran GALLIUM GA 68 GOZETOTIDE gallium ga-68 gozetotide SOLUTION;INTRAVENOUS 212643-001 Dec 1, 2020 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ge Healthcare GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 017700-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lantheus Medcl GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 017478-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Uihc Pet Imaging GALLIUM GA 68 EDOTREOTIDE gallium ga-68 edotreotide SOLUTION;INTRAVENOUS 210828-001 Aug 21, 2019 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.